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Substantia nigraIn Parkinson's disease (PD) the demonstration of neuropathological disturbances in nigrostriatal and extranigral
brain pathways using magnetic resonance imaging remains a challenge. Here, we applied a novel diffusion-
weighted imaging approach—track density imaging (TDI).
Twenty-seven non-demented Parkinson's patients (mean disease duration: 5 years, mean score on the Hoehn &
Yahr scale = 1.5) were compared with 26 elderly controls matched for age, sex, and education level. Track den-
sity images were created by sampling each subject's spatially normalized ﬁber tracks in 1 mm isotropic intervals
and counting the ﬁbers that passed through each voxel. Whole-brain voxel-based analysis was performed and
signiﬁcance was assessed with permutation testing.
Statistically signiﬁcant increases in track densitywere found in the Parkinson's patients, relative to controls. Clus-
ters were distributed in disease-relevant areas including motor, cognitive, and limbic networks. From the lower
medulla to the diencephalon and striatum, clusters encompassed the known location of the locus coeruleus and
pedunculopontine nucleus in the pons, and from the substantia nigra up to medial aspects of the posterior puta-
men, bilaterally.
The results identiﬁed in brainstem and nigrostriatal pathways show a large overlap with the known distribution
of neuropathological changes in non-demented PD patients. Our results also support an early involvement of lim-
bic and cognitive networks in Parkinson's disease.
© 2014 Elsevier Inc. All rights reserved.Introduction
Parkinsonism is clinically deﬁned by the presence ofmotor slowness
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366 29 46.1988). The most common cause of degenerative Parkinsonism in adults
is Parkinson's disease. The main motor features of Parkinson's disease
stem from the death of pigmented neurons in the substantia nigra
(SN). Neuronal loss begins in the ventrolateral SN and this remains
the most severely affected region throughout the illness (Damier et al.,
1999a; Fearnley and Lees, 1991). As the disease progresses, pathology
extends into the dorsal tier of the nigra and ventral tegmental area
(Fearnley and Lees, 1994). Post-mortem studies have shown that the
loss of cells in these regions results in profound dopamine (DA) deple-
tion in the motor region of the striatum (Kish et al., 1988), with nigral
projections to the dorsal and caudal putamen being most affected. A
post-mortem diagnosis of Parkinson's disease requires evidence of cell
loss in the SN, as well as the presence of Lewy pathology—a term that
describes variously shaped insoluble intraneuronal deposits that con-
tain misfolded α-synuclein. These aggregated α-synuclein deposits ac-
cumulate in neurites (Lewy neurites) and in neuronal somata (Lewy
bodies). Furthermore, neuropathological abnormalities can be observed
in other brainstem nuclei such as the pedunculopontine nucleus, locus
coeruleus, and raphe nucleus (Gesi et al., 2000; Halliday et al., 1990;
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brain and cerebral cortex, possibly according to a predictable spatiotem-
poral pattern (Braak et al., 2003a, 2003b).
In vivo nigral and extranigral imaging biomarkers of Parkinson's
disease are highly sought after for many reasons. Candidate biomarkers
may aid premotor diagnosis and help differentiate Parkinson's disease
from look-alike conditions such as essential tremor and atypical
Parkinsonian syndromes. Perhaps more importantly, reliable imaging
biomarkers may aid the development of disease-modifying therapies,
as they can be used to monitor disease progression.
To date, no in vivo brain imaging modality has adequately captured
the widespread spatial spectrum of brain abnormalities in non-
demented patients with Parkinson's disease. Because a biochemical
hallmark of Parkinson's disease is a deﬁciency of striatal DA,many imag-
ing studies have focused on studying the problem directly. Measure-
ment of striatal [18F]-L-dihydroxyphenylalanine (18F-DOPA) uptake
with positron emission tomography (PET) is regarded by many as the
“gold standard” for diagnosis of Parkinson's disease. However, while
decreased 18F-DOPA uptake may also be observed in other brainstem
regions and cortical areas (Pavese et al., 2012), it is generally acknowl-
edged that it does not reveal thewhole range of extranigral pathological
abnormalities.
Despite recent advances in brain imaging, extranigral abnormalities
remain difﬁcult to capture in vivo in non-demented Parkinson's pa-
tients. As routine MRI is typically unremarkable in Parkinson's disease,
the use of more advanced techniques is warranted. In this paper, we
used track density imaging, an advanced diffusion-weighted imaging
(DWI) method that allows the mapping of cerebral ﬁber pathways at
a spatial resolution smaller than the voxel size of the original MRI
(Calamante et al., 2010).
Diffusion-weighted imaging allows for the quantiﬁcation of water
mobility within tissue. In DWI analysis the movement of water within
each voxel ismodeled (e.g. using a tensor) and used for further analysis.
To date, most studies have relied on scalar measures derived from the
diffusion tensormodel, such as fractional anisotropy (FA) andmean dif-
fusivity (MD), which quantify the degree of anisotropy and average
magnitude of local water diffusion, respectively. Most previous DWI
studies in Parkinson's disease used FA andMD on focused regions of in-
terest deﬁned a priori, usually in the substantia nigra (Chan et al., 2007;
Vaillancourt et al., 2009; Yoshikawa et al., 2004; Zhan et al., 2011). In
general, results show decreased FA in Parkinson's patients compared
to controls. Studies in rat (Soria et al., 2011) and mouse (Boska et al.,
2007) models of Parkinson's disease have also reported similar de-
creases. Other studies using methods like tract-based spatial statistics,
voxel-based FA analysis, and ROIs outside the substantia nigra, have
resulted in less consistent reports. Changes in tensor-derived measures
have been reported in the gyrus rectus (Ibarretxe-Bilbao et al., 2010),
the genu of the corpus callosum, the superior longitudinal fasciculus
(Gattellaro et al., 2009), as well as motor and frontal cortices (Zhan
et al., 2011). As these past studies have relied on DWI sequences
with relatively low numbers of unique gradient directions [6 to 64,
(Cochrane and Ebmeier, 2013)], they may have lacked the sensitivity
to show disturbances using unbiased voxel-based analyses.
Here we acquired data in 27 non-demented Parkinson's disease pa-
tients and 26 matched controls using an advanced DWI sequence, in
which 120 diffusion gradients were applied, allowing for the ﬁtting of
higher order models of the signal in each voxel. We reconstructed
white matter streamlines from DWI images with constrained spherical
deconvolution, which generally provides far greater accuracy than alter-
natives like single ormulti-tensormodels (Tournier et al., 2004, 2008). In
this paper,when referring to the results of ﬁber tractography,wewill use
the terms “ﬁbers,” “tracks,” and “streamlines” interchangeably, and these
should not be confused with actual biological tracts (Jones et al., 2013).
The added value of track-weighted imaging comes from the infor-
mation obtained by tracking the neural pathways (Calamante et al.,
2012b). Track density imaging in essence is just the resampling of theﬁber track data into user-speciﬁed volumetric data (Calamante et al.,
2010). Sampling the tractography dataset with a voxel size smaller
than the original diffusion-weighted scan is known as “super-resolu-
tion” track-weighted imaging. In the approach presented here – track
density imaging (TDI) – the manufactured signal is simply the number
of streamlines passing through each voxel (Calamante et al., 2010). A
similar approach, average pathlength mapping, has shown promise for
evaluating traumatic brain injuries (Pannek et al., 2011). Streamline
density imaging has been validated histologically for its ability to re-
solve white matter boundaries (Calamante et al., 2012a).
The present study also differed from most previous DWI studies by
using a whole-brain voxel-based approach, rather than regions-of-
interest for data analysis. This allowed us to explore and test for changes
in both nigral and extranigral areas in the patients as comparedwith the
control groups. Based on the spatial distribution of neuropathological
abnormalities reported in non-demented Parkinson disease patients,
we hypothesized that differences in track density would appear pre-
dominantly in the brainstem and nigrostriatal pathways.
Materials and methods
Participants
We studied 27 (14 males) patients clinically diagnosed with
Parkinson's disease and 26 (14 males) healthy control subjects from a
larger data sample after excluding those with poor quality imaging
data. The groupswerematched by age, sex, and highest achieved educa-
tion level. Disease stage within the patient population was assessed in
the “on” state using the Hoehn & Yahr scale (Hoehn and Yahr, 1967).
Disease severity was evaluated using the Uniﬁed Parkinson's Disease
Rating Scale (UPDRS) (FahnandElton, 1987). Quality of lifewas estimat-
ed using the Parkinson's Disease Questionnaire (PDQ39) (Jenkinson
et al., 1997). Subjects were also administered several psychological
tests: global cognitive function [Mattis Dementia Rating Scale (Mattis,
1988), MMSE (Folstein et al., 1975), Symbol Digit Modalities test, verbal
ﬂuency test], inhibition [Stroop test, random number generation
(Jahanshahi et al., 2006)], episodic memory [Rey auditory verbal learn-
ing test (Rey, 1958)], updating of working memory [letter running
span memory task], cognitive ﬂexibility [Modiﬁed Wisconsin Card
Sorting Test], visuospatial judgment [Judgment of Line Orientation
(Benton et al., 1983)], and anxiety [Hospital Anxiety and Depression
Scale (Zigmond and Snaith, 1983)].
Twenty-four of the 27 patients were taking a combination of several
classes of drugs: levodopa (immediate and controlled release),
nonergot-derived dopamine receptor agonists (Pramipexole, Ropinirole),
and a monoamine oxidase B inhibitor (Rasagiline). The remaining 3 pa-
tients were not taking any anti-Parkinsonian medications at the time of
scanning. Levodopa and dopamine agonist dosages were pooled and
summarized as the levodopa equivalent daily dose [LEDD, (Hobson
et al., 2002)]. Total daily L-DOPA equivalent dosages ranged from 0 to
900 mg. Demographic and clinical data are summarized in Table 1. Writ-
ten informed consent was obtained from all participants in accordance
with the Declaration of Helsinki. The Ethics Committee of the University
of Liège approved the study.
Imaging data acquisition
Data were acquired on a 3 T head-only MR scanner (Magnetom
Allegra, Siemens Medical Solutions, Erlangen, Germany) operated with
an 8-channel head coil. Diffusion-weighted (DW) imageswere acquired
with a twice-refocused spin-echo sequencewith EPI readout at two dis-
tinct b-values (b= 1000, b= 2500 s/mm2) along 120 encoding gradi-
ents that were uniformly distributed in space by an electrostatic
repulsion approach (Jones et al., 1999). This sequence is designed spe-
ciﬁcally to reduce the distortions induced by eddy-currents in the
diffusion-weighted images (Reese et al., 2002). For the purposes of
2 Performed with the “gen_WM_mask” command in MRtrix.
Table 1







Age 64 (8) 66 (8) 0.549
Sex (M:F) 14:12 14:13
Years of education 13 (3) 11 (3) 0.133
ICV (mm3) 1478 (152) 1516 (148) 0.360
BMI (kg/m2) 25 (3) 25 (3) 0.660
Hand dominance (L:R) 2:24 2:25
Hoehn & Yahr stage 1.5 (0.62)
Most affected side (L:R) 10:17
Disease duration (years) 5 (3)
LEDD (mg) 323 (255)
UPDRS Section 2 9 (6)
UPDRS Section 3 14 (7)
Mattis 139 (4) 136 (4) 0.004
MMSE 29 (1) 28 (1) 0.022
HADS total 10 (4) 13 (6) 0.066
PDQ39 mobility 20 (18)
PDQ39 total 189 (114)
Rey Auditory Verbal
Learning Test
53 (11) 44 (11) 0.006
SDMT 51 (10) 45 (12) 0.062
JOLO 27 (4) 25 (4) 0.055
Values reﬂect mean (st. dev.). Two-tail t-tests were performed with an assumption of
unequal variance in each group. ICV = intracranial volume, BMI = body mass index,
LEDD = L-DOPA equivalent daily dose (Hobson et al., 2002), UPDRS = Uniﬁed
Parkinson's Disease Rating Scale, MMSE = Mini Mental State Examination, HADS =
Hospital Anxiety and Depression Scale, PDQ = Parkinson's Disease Questionnaire,
SDMT = Symbol Digit Modalities Test, JOLO = Judgment of line orientation test.
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the DW images, were acquired. Volumes were acquired with a repeti-
tion time (TR) of 6800 ms, an echo time (TE) of 91 ms, and a ﬁeld-of-
view (FOV) of 211 mm2. Maximum slew rate was 400 mT/(m/ms)
and maximum gradient amplitude was 40 mT/m. No parallel imaging
techniqueswere used. Themulti-channel head coil was used to increase
the signal-to-noise ratio, and not the speed of the acquisition. Volumes
were acquired with a 6/8 partial Fourier factor. Voxels were isotropic
with dimensions of 2.4 × 2.4 × 2.4 mm3 and volumes were acquired
in 54 transverse slices using an 88 × 88 voxel matrix. Total acquisition
timewas approximately 35min. MRI data were acquired while patients
were on their usual anti-Parkinsonianmedication so theywould remain
as still as possible in the scanner.
Structural and quantitativemaps of T1, T2*, proton density (PD) and
magnetization transfer (MT) at 1 × 1 × 1mm3 resolutionwere calculat-
ed from a multi-parameter protocol based on a 3D multi-echo fast low
angle shot (FLASH) sequence (Weiskopf and Helms, 2008). Three co-
localized 3D multi-echo FLASH datasets were acquired with predomi-
nantly proton density weighting (PDw: TR/α = 23.7 ms/6°), T1
weighting (T1w: 18.7 ms/20°), and MT weighting (MTw: 23.7 ms/6°;
excitation preceded by an off-resonance GaussianMT pulse of 4 ms du-
ration, 220° nominal ﬂip angle, 2 kHz frequency offset). The PDw acqui-
sition used eight bipolar gradient echoes at equidistant TE between
2.2 ms and 19.7 ms, whereas the T1w and MTw acquisition used six
bipolar gradient echoes at equidistant TE between 2.2 ms and 14.7 ms.
All three had 425 Hz/pixel bandwidth to avoid susceptibility-
related distortions. Volumes were acquired in 176 sagittal slices using
a 256 × 224 voxel matrix. The total acquisition timewas approximately
19 min.
A B1mapwas calculated using the actual-ﬂip-angle imagingmethod
(Yarnykh, 2007) based on two interleaved 3D FLASH acquisitions (rep-
etition times TR1=33ms, TR2=165ms, TE1=TE2=3.05ms, nominal
ﬂip angle = 60°, acquisition time = 5 min.). The B1 map was used to
correct the multiparameter maps for B1 ﬁeld bias (Volz et al., 2010).
Visual inspection of the raw images was performed to ensure that
subject data had no (i) ghosting, (ii) signal dropout, (iii) major motion
distortions, or (iv) scanner-induced vibration artifacts (Tournier et al.,
2011).Imaging data processing
Interleaved unweighted images from the diffusion sequence were
realigned to the ﬁrst unweighted volumewith a rigid body transforma-
tion using SPM8 (Wellcome Trust Centre for Neuroimaging, UCL, UK).
Registration was performed (rigid, mutual information) between the
ﬁrst unweighted volume and each of the interleaved unweighted vol-
umes (e.g. register b03 to b01). The translation and rotation values be-
tween b01 and b022 were linearly interpolated and applied to the
weighted volumes. The assumption behind this procedure is that the
subject's displacement was linearly continuous in between unweighted
volumes. This put all theweighted images in alignmentwith the ﬁrst b0
volume without the contrast problems of co-registering weighted and
unweighted images. Diffusion gradient vectors were rotated according-
ly (Leemans and Jones, 2009). For each diffusion-weighted volume, a
non-local mean ﬁlter was applied (Maggioni et al., 2013) and noise
was corrected using power image correction adapted for multi-coil ac-
quisitions (André et al., 2014). No further corrections were applied to
correct for eddy current-induced distortions in the diffusion-weighted
volumes because the diffusion sequence did a sufﬁcient job of suppress-
ing them.
We included motion as a nuisance regressor in our analysis by com-
puting a version of the totalmotion index (Yendiki et al., 2014) from the
rigid transformations between unweighted volumes. We calculated av-
erage volume-by-volume translation between unweighted images by
averaging the magnitude of the translation vectors between each suc-
cessive unweighted image. Similarly, average volume-by-volume rota-
tion was computed by averaging the sum of the absolute values of the
rotation values between successive unweighted images.
FA and MD maps
A brainmask was generated using the “median Otsu”method as im-
plemented in Dipy (version 0.7.1) (Garyfallidis et al., 2014). In this
method, a median ﬁlter is applied to smooth the unweighted volume,
and then an automated histogramapproach is used to separate the fore-
ground and background. Using the low b-value (b=1000 s/mm2) data,
tensors were ﬁt at each voxel using non-linear least squares, and frac-
tional anisotropy and mean diffusivity maps were also generated from
the tensors.
TDI maps
The ﬁber response model was estimated for each subject from the
high b-value (b= 2500 s/mm2) diffusion-weighted images. A mask of
single ﬁber voxels was extracted from the thresholded and eroded FA
images. Only strongly anisotropic (FA N 0.7) voxels were used to esti-
mate the spherical-harmonic coefﬁcients of the response function
(Tournier et al., 2004, 2008). Using non-negativity constrained spherical
deconvolution, ﬁber orientation distribution (FOD) functions were ob-
tained at each voxel.
For both the response estimation and spherical deconvolution steps
we chose a maximum harmonic order of 8. Seed masks were created
from white matter probability maps, estimated from signal variation
in the DWIs,2 thresholded above 0.4. This threshold was chosen by
trial and error, and is in general lower than what would be used on
young healthy subjects, possibly due to variations in levels of iron
(Graham et al., 2000). Probabilistic tractography was performed using
randomly placed seeds within subject-speciﬁc white matter masks.
Fiber tracking settings were as follows: number of tracks = 5,000,000,
FOD magnitude cutoff for terminating tracks = 0.1, minimum track
length = 10 mm, maximum track length = 200 mm, minimum radius
of curvature = 1 mm, tracking algorithm step size = 0.2 mm.
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matter mask, or (ii) could not progress along a direction with an FOD
magnitude or curvature radius higher than the minimum cutoffs.
Spatial normalization of the ﬁber tracks followed a procedure laid
out previously (Pannek et al., 2011). First, track density and total
pathlength maps (TPM) were generated with 1 × 1 × 1 mm3 isotropic
voxels, and used to create average pathlength maps (TPM/TDI =
APM) for each subject. The APMs were then rigidly aligned to the
MNI152 1 mm T1 template with mutual information and averaged to
create an initial template. The APMs were then used to build a template
through 4 iterations, beginning with an initial afﬁne transformation
followed by greedy symmetric diffeomorphic normalization (SyN)
with cross-correlation (Avants et al., 2010, 2011). For each subject, the
transformations (rigid, afﬁne, warp) were then individually inverted
and applied in inverse order to a unit warp ﬁeld generated in the ﬁnal
template space.3 This was then used to normalize the tracks into tem-
plate space with MRtrix, by warping each point along the ﬁbers. Finally,
track density images were generated from the normalized tracks, again
with 1 × 1 × 1 mm3 isotropic voxels. Normalization steps were per-
formed using Advanced Normalization Tools (ANTS, http://www.picsl.
upenn.edu/ANTS/). No spatial smoothing was applied.
Motion-corrected DWIs were assessed to ensure that the correction
procedure performed adequately. Inspection of the scalar images, such
as FA, MD, seed masks, single-ﬁber response estimation masks, APM,
and pre- and post-normalization TDIwas also performed. Track datasets
were truncated to 100,000 tracks to assess registration with the tem-
plate using MRview (Tournier et al., 2012). Diffusion-weighted image
and ﬁber track processing was performed with the MRtrix package
version 0.2.12 (J-D Tournier, Brain Research Institute, Melbourne,
Australia, http://www.brain.org.au/software/) (Tournier et al., 2012).
The tractography and spatial normalization workﬂows were developed
in Python with the Nipype pipeline architecture and are freely available
online (Gorgolewski et al., 2011).
MT maps
For display purposes, semi-quantitative MT saturation maps were
calculated within SPM8. These MT maps show the percentage loss of
magnetization imposed by a single MT pulse (Draganski et al., 2011).
The contrast in these MT images, which is higher than in typical T1-
weighted images, enables more accurate distinction between gray and
white matter, especially for the basal ganglia and substantia nigra
(Helms et al., 2009). MT maps were processed using uniﬁed segmenta-
tion in order to create masks of gray matter, white matter, and cerebro-
spinal ﬂuid (Ashburner and Friston, 2005). Diffeomorphic registration
(DARTEL) was used to normalize the MT maps to a common template
(Ashburner, 2007). Target images for the DARTEL registration were
modiﬁed tissue probability maps from previous MT segmentations
(Draganski et al., 2011), which included detailed segmentation of sub-
cortical regions.
Todisplay theﬁnal results, the studymeanMTmapwas coregistered
to the average TDI map with an initial rigid and secondary afﬁne trans-
formation using mutual information. Greedy symmetric diffeomorphic
normalization with Mattes mutual information was used register the
mean TDI map with the MNI152 1 mm T1 template. The identiﬁed
transformation was applied to the mean MT image. Registration was
performed in ANTs and accuracy was assessed visually at each step.
Statistical analysis
FA and MD data
Voxelwise statistical analysis of the FA data was carried out using
tract-based spatial statistics (TBSS) (Smith et al., 2006), part of FSL 5.13 Performed with the “gen_unit_warp” command in MRtrix.(Smith et al., 2004). TBSS projects all subjects' FA data onto a mean FA
tract skeleton, before applying voxelwise cross-subject statistics. TBSS
was also carried out on the mean diffusivity (MD) images. Non-
parametric statistics were performed using FSL's Randomise (5000 iter-
ations), and2D Threshold-Free Cluster Enhancement (TFCE) (Smith and
Nichols, 2009)with themean-centered totalmotion index as a nuisance
covariate.
TDI data
An optimal white matter mask was generated from all of the track
density images using the SPM8 Masking toolbox and the Luo-Nichols
anti-mode method of automatic thresholding (Luo and Nichols, 2003;
Ridgway et al., 2009). Permutation testing was performed using
Randomise (5000 iterations)with TFCE and themean-centered totalmo-
tion index as a nuisance covariate. Only clusters with p b 0.05 after
correcting for family-wise error rate were considered statistically signiﬁ-
cant. Tentative anatomical labelswere estimated from a number of freely
available brain atlases. Brainstem regions were examined by comparison
with a high-resolution single subject DTI scan (Aggarwal et al., 2013).
Cortical clusters were localized with the JHU ICBM-DTI-81 white-
matter atlas (Oishi et al., 2010), the JHU white-matter tractography
atlas (Hua et al., 2008), and the Jülich Histological Atlas (Bürgel et al.,
2006).
Pearson correlation was used to explore interactions with numeric
clinical metrics (e.g. UPDRS III score). The Spearman rank-order correla-
tion coefﬁcient was used for non-numeric variables (e.g. Hoehn and
Yahr stage). Bonferroni correction was used to account for the number
of independent statistical tests. Between-group differences in psycho-
logical metrics, as well as total motion index, were assessed with a
two-sample t-test with an assumption of unequal variance.
Data were processed using the NITRC Computational Environment
for Cluster Compute Instances using Amazon Elastic Compute Cloud
(EC2) servers. The virtual machine snapshot is available upon request.
Results
Behavioral data
In our cohort the Parkinson's disease patients scored signiﬁcantly
lower than controls on theMattis scale, mini-mental state examination,
and the episodic memory test (Rey auditory verbal learning test), sug-
gesting mild cognitive disturbances. Apart from these, there were no
statistically signiﬁcant differences between the patients and controls
on any of the psychological measures. Every patient's performance
was above the standard cutoff threshold for the Mattis dementia rating
scale (Llebaria et al., 2008), and none of them met standard criteria for
dementia associated with Parkinson's disease (Emre et al., 2007). The
group mean total motion index was larger in PD patients than controls,
but this did not reach statistical signiﬁcance (p= 0.053).
Tract-based spatial statistics (TBSS) on FA and MD maps
No statistically signiﬁcant results were obtained from the TBSS anal-
ysis for either FA or MD images.
Voxelwise analysis of TDI map
Statistically signiﬁcant increases in track density in Parkinson's dis-
ease, relative to controls, were found in brainstem and extrapyramidal
motor networks, limbic, and cognitive circuits. Areas of increased TDI
were strikingly symmetric between hemispheres. Fig. 1 shows axial
slices of the populationmeanMT image,with the clusters containing sig-
niﬁcantly increased TDI overlaid. There were no statistically signiﬁcant
decreases in track density in the Parkinson's patients, compared to con-
trols. To clarify the widely distributed but signiﬁcant results, we lowered
the statistical threshold to 0.01 (family-wise error rate corrected). The
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umented in Table 2.
Brainstem and extrapyramidal motor networks
The brainstem and cerebellar peduncles showed widely increased
TDI in the patients. Results projected onto the brainstem portion of
the superior, middle, and inferior cerebellar peduncles, as well as the
pontine crossing tract and themedial lemnisci. Brainstem nuclei also af-
fectedwere the locus coeruleus, pedunculopontine nucleus, ventral teg-
mental area, and raphe nucleus.
Increased track density was found bilaterally in a pattern appearing
to connect the substantia nigra and striatum. The signiﬁcant regions
encompassed the caudal ventral substantia nigra and extended dorsally
toward the medial aspects of the posterior putamen. A coronal slice
through the substantia nigra with the signiﬁcantly (pFWE b 0.01) affect-
ed areas overlaid is shown in Fig. 2.
Limbic circuits
TDI increases were found in the ventral tegmental area and in white
matter regions surrounding the ventral striatum both medially and lat-
erally. The pallidum, as well as the anterior and dorsomedial nuclei of
the thalamus were also affected. At the cortical level, the entire cingu-
lum was affected heavily in the right hemisphere, but only in posterior
regions of the left hemisphere. Bilateral increases in TDI were also
found in the orbitofrontal cortex. Fig. 3 shows slices of affected areas
in the limbic system.
Cognitive circuits
Increased streamline density in Parkinson's patients was found in
many areas of the cerebral white matter. Major associative pathways
such as the superior and inferior longitudinal fasciculi (SLF, ILF) showed
sections of increased TDI.
In the frontal cortex, the genuof the corpus callosumand areas of the
anterior corona radiata were affected. The superior parietal lobule was
widely affected, ostensibly by changes to the superior longitudinal fas-
ciculi. Regions in the primary somatosensory cortices (BA2, BA3b)
were notably affected. The anterior temporal poles were clearly affected
by variations along the inferior longitudinal fasciculi. The occipital cor-
tex was also affected, speciﬁcally in regions of the inferior fronto-
occipital fasciculi, posterior thalamic radiations, optic radiations, and
the forceps major. Fig. 4 shows affected areas involved in cognition.
Discussion
This whole brain voxel-based advanced MRI study identiﬁed
brainstem and nigrostriatal pathways as signiﬁcantly affected brain
areas in non-demented Parkinson's disease patients as compared with
controls. To the best of our knowledge, this is the ﬁrst time a single
MRI method has identiﬁed abnormalities projecting onto these areas.
This is consistent with the known distribution of neuropathological ab-
normalities in early-stage Parkinson's disease (Braak et al., 2003b).
Our whole-brain voxel-based analysis also revealed signiﬁcantly in-
creased streamline density in cognitive and limbic networks. Since pa-
tients enrolled in the present study were in the ﬁrst years after the
diagnosis, dementia-free, and without major cognitive or behavioral
deﬁcits at the time of scanning (Table 1), it would be valuable to test
if these imaging ﬁndings are predictive of further clinical deterioration.Fig. 1.Overview of the increases in track density. Group-level statisticalmap of increased stream
transfer image. MNI coordinates in millimeters are displayed on top of each slice. Clusters show
estimated with threshold-free cluster enhancement.Brainstem and extrapyramidal motor circuits
Dopaminergic denervation within the nigrostriatal pathway is the
most well described neuropathological feature of Parkinson's disease,
but to date, no MRI modality has been sensitive enough to clearly iden-
tify alterations to this pathway. The method used here was able to cap-
turemicrostructural abnormalitieswithin both the SN andﬁber tracts to
the striatum. Track density abnormalities predominated in the ventro-
lateral portion of the substantia nigra. This is consistentwith neuropath-
ological observations in Parkinson's disease (Fearnley and Lees, 1991),
as the greatest dopaminergic cell loss occurs in nigrosome 1 of the
substantia nigra pars compacta, which is in the caudal and ventrolateral
region of the SN (Damier et al., 1999b).
Compared to controls, patients showed increased ﬁber density from
the SN to the posterior part of the putamen, which is predominantly in-
volved in motor circuits with the (pre)motor cortices. This ﬁnding is in
agreement with post-mortem studies in Parkinson's patients that typi-
cally showprofounddopamine depletion in themotor region of the stri-
atum (Kish et al., 1988), with nigral terminals in the dorsal and caudal
putamen being most affected.
We were unable to replicate ﬁndings of decreased FA at the level of
the substantia nigra (Chan et al., 2007; Peran et al., 2010; Vaillancourt
et al., 2009; Yoshikawa et al., 2004; Zhan et al., 2011). There are many
possible factors that could explain the lack of signiﬁcant changes in
tensor-derived indices in our sample. First, DWI scanning parameters
differ enormously between studies, with many of the previously pub-
lished studies reporting data with 1.5 T scanners, using thick slices
(which can include peri-nigralﬁber tracts), and applying very fewdiffu-
sion directions. Second, nearly all of these studies use ROIs drawn on
FA or T1-weighted images, neither of which clearly delineates the
substantia nigra. Third, the number of subjects is also quite low in
many studies, and patient disease stage varies bothwithin and between
studies. Furthermore, our patient population is fairly early stage (mean
Hoehn and Yahr stage: 1.5), and though pathological damage to the SN
occurs well before symptom onset, it also continues as the disease pro-
gresses. A recent meta-analysis of the literature concluded that there is
no signiﬁcant disease effect on mean diffusivity (Schwarz et al., 2013),
and that there is extremely large variation in the results presented on
FA. They also reported that after excluding studies with unusually
high values of nigral FA in the control groups, therewasnodisease effect
on FA, either.
Increased TDIwas found in caudal brainstem areasmainly in its pos-
terior aspect. Wemust acknowledge that the spatial resolution of diffu-
sion weighted MRI might be insufﬁcient for accurate labeling of results
given the anatomical complexity of the brainstem. Anatomical labeling
of the involved structures is tentative, rather than deﬁnitive, and should
be interpreted with caution. Signiﬁcant clusters projected onto the
known location of the locus coeruleus and pedunculopontine nucleus,
ventral tegmental area, raphe nucleus, and pontine crossing tract.
The pedunculopontine area is heterogeneous in composition and
contains cholinergic, GABAergic, and glutamatergic neurons. The PPN
is heavily affected in Parkinson's disease, and the loss of roughly 50%
of its cholinergic neurons (Jellinger, 1988) has been correlatedwith dis-
ease stage (Rinne et al., 2008). Neuropathological abnormalities in the
pedunculopontine area and its connections with basal ganglia, cerebral
cortex, cerebellum, and spinal cord are considered to be pivotal, not
only for disturbances of gait and posture, but also for non-motor prob-
lems related to arousal and cognition (Benarroch, 2013; Stefani et al.,
2013).
These results are also consistent with the reduction in medium-sized
locus coeruleus neurons found in Parkinson's disease (Patt and Gerhard,
1993). In the post-mortem brain tissue of Parkinson's patients theline density throughout the brain. Clusters are overlaid on the group-meanmagnetization
n in blue are signiﬁcant at pFWE b 0.05 and those in red are signiﬁcant below pFWE b 0.01,













3062 416.5 708.6 70% Brainstem, substantia nigra, superior cerebellar peduncle, nigrostriatal pathway Bilateral 0,−31,−26 −2,−40,−49
1267 511.3 733.0 43% Optic radiation Right 32,−72, 16 39,−70, 18
1030 674.5 981.7 46% Posterior inferior fronto-occipital fasciculus Right 41,−48, 9 38,−45, 11
814 685.6 959.6 40% Superior longitudinal fasciculus, parietal lobe Right 36,−18, 31 37,−24, 29
434 324.2 517.2 60% Middle cerebellar peduncle Bilateral −3,−23,−39 6,−17,−39
302 477.2 697.4 46% Anterior inferior longitudinal fasciculus Right 44,−23,−15 46,−14,−25
133 114.2 246.4 116% Lateral occipital cortex Right 55,−62, 1 59,−62,−1
109 935.9 1474.1 58% Superior longitudinal fasciculus, parietal lobe Left −33,−20, 27 −32,−18, 26
97 539.6 767.6 42% Superior longitudinal fasciculus, parietal lobe Right 42,−36, 34 45,−37, 35
85 816.3 1218.7 49% Superior longitudinal fasciculus, parietal lobe Left −29,−23, 37 −30,−21, 37
75 1112.5 1684.6 51% Superior longitudinal fasciculus, parietal lobe Right 35,−39, 23 36,−40, 23
38 231.9 433.8 87% Posterior cingulum Left −11,−36, 37 −11,−36, 36
34 713.7 1035.9 45% Corona radiata near somatosensory cortex Left −20,−44, 43 −20,−44, 44
25 370.6 544.7 47% Anterior superior longitudinal fasciculus Left −41,−13, 28 −41,−12, 27
20 657.9 1044.8 59% External capsule Left −32,−4,−12 −33,−4,−12
18 538.6 790.9 47% External capsule Right 30,−13,−9 30,−14,−9
17 982.3 1478.5 51% Posterior optic radiation Right 32,−56, 18 32,−55, 18
14 206.1 320.5 56% Occipital cortex Right 29,−79, 27 29,−78, 26
10 318.5 604.1 90% Precuneus Right 16,−42, 43 16,−42, 43
Information about signiﬁcant (pFWE b 0.01) clusters identiﬁed in the study. Percent signal change in Parkinson's disease within each cluster was calculated using (TDIPD − TDIHC)/TDIHC.
Clusters were largely bilateral. The largest cluster encompassed the substantia nigra and extended upwards to the striatum, bilaterally.
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is around 70% (Bertrand et al., 1997; Zarow et al., 2003). Furthermore,
connections between the locus coeruleus and the cerebellum, thalamus,
and cerebral cortex are known to inﬂuence locomotion (Watson and
McElligott, 1984) and arousal. Detriments in both of these systems are
considered cardinal signs of Parkinson's disease (Lima, 2013).
In this study theproximal parts ofmiddle and superior cerebellar pe-
duncles were affected bilaterally. Previous ROI-based studies did not
identify any changes in these areas in Parkinson's disease (Nicoletti
et al., 2008; Paviour et al., 2007), although both relied on relatively
poor quality diffusion data. The superior cerebellar peduncles contain ﬁ-
bers that connect the locus coeruleus and pedunculopontine nucleus
with deep cerebellar nuclei and the cortex (Hazrati and Parent, 1992;
Liu, 2012). Clinically relevant cerebellar involvement is uncommon in
Parkinson's disease, though, and methodological issues may contribute
collectively to the results identiﬁed in this region.
In the raphe nucleus, evidence for neuronal loss is less consistent.
Somepost-mortem studies of patientswith Parkinson's disease have re-
vealed a profound loss of 5-HT neurons (Jellinger, 1991) and their ter-
minals (Birkmayer and Birkmayer, 1987; Kish et al., 2008), although
other studies have not. This variability may contribute to the heteroge-
neity in mood disturbances found in Parkinson's patients.
Limbic network
Increased TDI was found bilaterally in limbic areas including the
ventral tegmental area, ventral striatum,medial thalamus, orbitofrontal
and anterior cingulate cortices.
The VTA loses considerable amounts of dopaminergic neurons in pa-
tients with Parkinson's disease (Uhl et al., 1985). The ventral tegmen-
tum is populated largely by dopaminergic neurons and is tightly
linked with the reward circuit of the nucleus accumbens (Sesack and
Grace, 2009). It projects to the forebrain and limbic system and a loss
of integrity in these pathways may inﬂuence patients' emotional state.
In this study the patients showed a trend toward increased anxiety
and depression, but scores on the HADS scale did not reach the thresh-
old for the diagnosis of depression (Table 1).
Regions corresponding to the anterior and dorsomedial thalamic nu-
clei were found to have increased TDI in PD. The anterior, dorsomedial,
and ventral anterior thalamic nuclei have previously been shown to
have reduced FA in Parkinson's disease (Planetta et al., 2013). Boththe anterior and dorsomedial nuclei are involved in the limbic system.
The anterior nucleus projects to the cingulate gyrus, whereas the
dorsomedial nucleus connects to the amygdala, anterior cingulate, and
prefrontal cortices.
Cognitive circuits
The patients in this study were in early stages of the disease and
showed no evidence of dementia. For this reason we did not expect to
ﬁnd substantial abnormalities in the cerebral cortical areas. Neuropsy-
chological testing, however, did indicate very mild cognitive distur-
bances in the patients.
Clusters of signiﬁcantly increased TDI in patients projected primarily
onto posterior areas of the cerebral white matter. The corresponding
cortical areas consistently show disturbed resting-state activity in
PD populations studied using functional imaging methods such as
18F-ﬂuorodeoxyglucose PET and arterial spin labeling (Garraux et al.,
2011; Hu et al., 2000; Melzer et al., 2011; Tang et al., 2010). Our study
supports the hypothesis that altered activity in these areasmay be relat-
ed to damage within white matter pathways targeting these areas. This
may contribute to the mild cognitive disturbances found in PD patients
when compared with controls. Our transversal study design does not
allow us to test whether or not altered white matter tracts in posterior
areas are predictive of future cognitive deterioration.
Methodological considerations
Our analysis, unexpectedly, showed an increase in streamline densi-
ty in the PD patients. The reason for this increase is unclear, though, so
we are forced to speculate as to its cause.We have identiﬁed several po-
tential sources of error. The ﬁrst relates to the calibration and use of
constrained spherical deconvolution to ﬁt ﬁber orientation distribution
models to the DWI data.
The key assumption behind spherical deconvolution approaches is
that themeasured signal in any voxel is a convolution of the ﬁber orien-
tation distribution in that voxel and the diffusion-weighted signal re-
sponse for a single-ﬁber population. The single-ﬁber response in this
study is estimated on a subject-by-subject basis and assumed to be con-
stant throughout the brain. The ﬁber response functions are approxi-
mated by a linear combination of spherical harmonic basis functions,
which in this study, were truncated at the 8th order harmonic. The
Fig. 2. Substantia nigra cluster. Single coronal slice showing the cluster that encompasses
the substantia nigra (pFWE b 0.01). The cluster is overlaid on the study mean MT map, so
that the SN is more visible. This cluster extends upward through the cerebral peduncles
and terminates at the posterior medial putamen.
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has recently been shown to be negligible for the b-value used in this
study (b=2500 s/mm2) (Tournier et al., 2013). In this study, highly an-
isotropic (FA N 0.7) voxels were assumed to contain a ﬁber population
oriented in a single direction, and used for ﬁber response calibration.
These were extracted from an eroded FA image so that voxels at the
edges of the brain, which are more prone to artifacts, were not consid-
ered. Future studies may consider adding a calculation of tensor mode
(Ennis and Kindlmann, 2006) to help select voxels for calibration. Itera-
tive (Tournier et al., 2013) and recursive (Tax et al., 2014) methods for
CSD calibration have also recently been demonstrated. In our study the
calibration valueswere not found to differ between groups (two sample
t-test, unequal variance, data not shown).
One possible source of error is potential incongruity between the ap-
proximated ﬁber response function and the actual ﬁber response func-
tion found in chronically damagedﬁber tracts. It has been demonstrated
that poor estimates of ﬁber response function, (e.g. caused by calibrat-
ing the response function from voxels with multiple ﬁber populations)
can lead to spurious ﬁber orientations being resolved (Parker et al.,
2013). These artifactual ﬁber orientations may be especially apparent
in regions with complexmicro- andmacro-structural properties, multi-
ple ﬁber populations, or partial volume effects.We applied the standard
threshold of FOD magnitude N 0.1, which substantially reduces the
number of spurious peaks capable of disrupting the tractography algo-
rithm (Parker et al., 2013).
It remains unclear how researchers should proceed when
performing spherical deconvolution within pathological populations
containing local changes in microstructural properties. Image-wideFig. 3. Limbic system clusters. Limbic involvement was widespread, involving the cingulum, or
mean TDI map. Clusters in blue are signiﬁcant below pFWE b 0.05 and clusters in red are signiﬁﬁber response calibration may not be the best solution for pathological
brains. Lowering the maximum harmonic order allowed in constrained
spherical harmonic deconvolution (CSD) can reduce its sensitivity to
miscalibration (Parker et al., 2013). Other alternatives to CSD that may
reduce spurious ﬁber orientations are damped Richardson–Lucy
deconvolution (Dell'Acqua et al., 2010) and voxel-by-voxel response es-
timation (Anderson, 2005).
The second concern involves the white matter masking and
tractography seeding used in this study. We estimated white matter
masks from the signal variation in the DWIs, and because this technique
was used, they may have differed in spatial extent between subjects.
White matter masks should be segmented carefully from high-
resolution structural images and subsequently co-registered todiffusion
space. It may also be beneﬁcial to seed a speciﬁc number of tracks from
every white matter voxel, rather than a large number from randomly
chosen masked voxels.
One notable subjective choice in this study was the resolution of the
TDI and APMmaps.We chose 1mm3 isotropic voxels based on our own
testing and because track quantiﬁcation studies at this resolution have
been previously published (Besseling et al., 2012; Pannek et al., 2011).
The primary requirement for the TDI and APM resolution is that it
should provide reliable maps with small variability across subjects, so
that template building and normalization are performed accurately.
The choice of spatial resolution for track quantiﬁcation studies is highly
dependent on the amount of tracks the image is being sampled from. In
our study, each subject was seeded with 5 million tracks, and we found
that this led to reliable TDI maps with 1 mm3 isotropic voxels. Smaller
voxel sizes led to maps with distributed empty voxels and greatly
increased the computational cost during both TDI generation and nor-
malization. Optimal settings for track quantiﬁcation need to be stan-
dardized for it to become widely adopted.
This study was performed carefully and differences between groups
were assessed conservatively. Our results demonstrate that TDI is
affected in Parkinson's disease in speciﬁc areas of the brain, many of
which have been previously linked to known dysfunctions. If these
changes were global or randomly located they would not have been
identiﬁed as signiﬁcant by group-wise statistical tests.
Track-weighted imaging is inherently a non-local analysis tech-
nique. That is, biological changes or artifacts that are present in one re-
gion will impact the track-weighted measures sampled in other voxels
traversed by the same tracks. This quality of track density imaging
also likely contributed to our widely spatially distributed results. Even
if the above issues are resolved, TWI may be more appropriate (and in-
terpretable) in pathologies where there are only a small number of af-
fected tracts.
The clinical relevance of neuroimaging ﬁndings when patient and
control groups are compared is usually appreciated by testing for a sim-
ple relationship between clinical and imaging data. Our analysis did not
identify any signiﬁcant linear correlation between streamline density
and individual performance in motor and cognitive tests: individualsbitofrontal cortex, anterior and dorsomedial thalamus. Clusters are overlaid on the study
cant at pFWE b 0.01.
Fig. 4. Cognitive network clusters. White matter tracts involved in cognitive function were notably affected. The superior and inferior longitudinal fasciculi, superior parietal lobule, and
occipital cortex showed increased track density. Clusters are overlaid on the study mean TDI map. Clusters shown are signiﬁcant at pFWE b 0.01.
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bances. This may suggest that the streamline density imaging method
used in the present study is a biomarker of disease traits but may not
be appropriate to monitor disease severity. Several other effects also
need to be considered including compensatory mechanisms by
exogeneous factors, such as anti-Parkinsonian medications at the time
of clinical testing, endogeneous processes (i.e., neural network compen-
satory mechanisms), or a combination of both.
Potential future track quantiﬁcation studies may want to consider
using (i) outlier rejection methods like HOMOR (Pannek et al., 2012),
(ii) lower maximum harmonic orders for CSD, or damped Richardson-
Lucy deconvolution (Parker et al., 2013), (iii) templates created from
subjects' FOD (Raffelt et al., 2011), (iv) anatomically constrained
tractography (Smith et al., 2012) and ﬁltering of tractograms given
information from spherical-deconvolution (Smith et al., 2013), and
(v) more reliable track-weighted imaging approaches (Besseling et al.,
2012; Willats et al., 2014). Another method to consider may be direct
comparison of FOD functions using apparent ﬁber density, which has
proven successful in motor neuron disease (Raffelt et al., 2012). Global
tractography approaches are also becoming feasible for widespread
use (Reisert et al., 2010) and can provide more biologically plausible
tractograms.
Conclusion
We have performed track density imagingwithin a large population
of early-stage patients with Parkinson's disease and a group of matched
healthy controls. Our cross-sectional analysis revealed increased
streamline counts in Parkinson's disease within various white matter
pathways traditionally involved in brainstem and extrapyramidal func-
tions, limbic, and cognitive processes. Themost remarkable result is the
involvement of the nigrostriatal pathways extending dorsally from the
ventrolateral part of the SN and terminating at themedial posterior pu-
tamen bilaterally.
Various sources of error and/or processing steps taken may have
contributed to the increase in track density we observed in our patient
population. At this point this confounds a biological interpretation of
our results. What is clear is that track quantiﬁcation can provide com-
plementary information to standard diffusion analysis methods, and
that it can be used to map both nigral and extranigral abnormalities in
Parkinson's disease.
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